Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a networkmeta-analysis (Protocol)

Battle, C. E., Abdul-Rahim, A. H., Shenkin, S. D., Hewitt, J. and Quinn, T. J. (2019) Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a networkmeta-analysis (Protocol). Cochrane Database of Systematic Reviews, 4, CD013306. (doi: 10.1002/14651858.CD013306)

[img]
Preview
Text
184004.pdf - Published Version

220kB

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of each cholinesterase inhibitor in the treatment of adults with VCI. To compare cholinesterase inhibitors for efficacy and safety in people with VCI.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Abdul-Rahim, Dr Azmil and Quinn, Dr Terry
Authors: Battle, C. E., Abdul-Rahim, A. H., Shenkin, S. D., Hewitt, J., and Quinn, T. J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:Cochrane Database of Systematic Reviews
Publisher:Wiley
ISSN:1469-493X
ISSN (Online):1469-493X
Published Online:01 April 2019
Copyright Holders:Copyright © 2019 The Cochrane Collaboration
First Published:First published in Cochrane Database of Systematic Reviews 4:CD013306
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record